AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...
Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...
Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...
Medical Device Network on MSN3d
University Hospitals Cleveland set to evaluate AI for early lung cancer detectionUniversity Hospitals plans to compare Qure.ai’s lung cancer algorithm against radiologists’ X-ray interpretations.
The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback